Diminution of chemically induced lung neoplasia in mice by phenobarbital pre-treatment

Area of Science:

• Oncology
• Pharmacology
• Toxicology

Background:

• Lung tumorigenesis is a complex process influenced by various carcinogens.
• Chemoprevention strategies aim to reduce cancer incidence or progression.
• Phenobarbital is a known inducer of drug-metabolizing enzymes, potentially affecting carcinogen metabolism.

Purpose of the Study:

• To investigate the chemopreventive effects of phenobarbital on chemically induced lung tumorigenesis in mice.
• To determine if pre-treatment, post-treatment, or prolonged administration of phenobarbital influences tumor yield.

Main Methods:

• ICR/Jcl mice were used, with varying ages for different experimental groups.
• Lung tumors were induced using carcinogens such as 4-nitroquinoline-1-oxide (4NQO), furylfuramide, dimethylbenz[a]anthracene (DMBA), and urethane.
• Phenobarbital was administered at different doses (75 µg/g or 40 µg/g) and schedules (pre-treatment, post-treatment, consecutive treatments).

Main Results:

• Pre-treatment with phenobarbital (75 µg/g) significantly reduced lung tumor yields induced by 4NQO and furylfuramide.
• DMBA- and urethane-induced lung tumorigenesis showed a reduction with pre-treatment, but not statistically significant.
• Six consecutive treatments with phenobarbital (40 µg/g) in adult mice significantly reduced urethane-induced lung tumorigenesis.
• Post-treatment with phenobarbital did not significantly alter tumor yields for any carcinogen tested.

Conclusions:

• Phenobarbital exhibits chemopreventive potential against certain carcinogen-induced lung tumors, particularly when administered prior to or during exposure.
• The timing of phenobarbital administration is crucial, with pre-treatment and consecutive treatments showing efficacy, while post-treatment does not.
• These findings highlight the importance of drug administration timing in chemoprevention strategies for lung cancer.